st-400
Showing 1 - 1 of 1
After Ex-vivo Gene Therapy With BIVV003 in Severe Sickle Cell
Recruiting
- Blood and Lymphatic Diseases
- BIVV003
- ST-400
-
Detroit, MichiganInvestigational Site Number :8400001
Jul 6, 2022